3 professionals
Interest of a cleanser product on subjects with mild to moderate acne and very dry skin due to acne treatments
Interest of a cleanser product on subjects with mild to moderate acne and very dry skin due to acne treatments
Helena Polena1, Michèle Sayag1 and Christelle Graizeau1,2
1NAOS Group, Research and Development Department, Aix-en-Provence, France
2NAOS Institute of Life Science, Aix-en-Provence, France
Related topics
Topical or oral retinoids use are one of the standard therapeutics in acne. They provide anti-inflammatory effects and reduce comedones, but lead to several cutaneous side effects, such as local skin irritation, dehydration, desquamation, pruritus, and lipid level alteration at the surface of the skin, which intensity depends on their concentration and formulation of the product. Biologically, these side effects are related to an excessive decrease in sebum production and an altered skin barrier, representing a key issue in patients’ adherence to treatment. Therefore, the aim of this study was to evaluate, under dermatological and ophthalmological control, the safety and the subjective efficacy of a cleansing product in promoting skin comfort to patients undergoing retinoid treatment.
In an observational, blinded control study, which includes two visits at day(D)0 and D28, 30 subjects, aged from 14 to 29 years (mean: 20.6 years) under treatment with mild to moderate acne and very dry skin were included and used the studied product on the face twice daily for 28 days. The Subjects Global Assessment (SGA) of acne severity was evaluated by the subjects at the end of study. Cutaneous and ocular safety assessments were performed at D0 and D28 by a dermatologist and ophthalmologist, respectively. The skin hydration and the lipidic index measurements were performed at each visit. In the same way, the efficacy and the cosmetic properties appreciation of the product were evaluated by the subjects at D0 and D28.
All subjects were compliant with the treatment and 80% of them had a remarkable improvement in terms of acne severity comparing to D0. For 28 days of product use, no cutaneous and ocular reactions or discomfort sensations ascribable to the tested product were reported. The skin hydration was significantly improved by 53.1%, and no significant decrease in the lipidic index was observed compared to D0. The gently cleansing of the product was validated by 100% of the subjects as well as the soothing effect by 90% at D28. All subjects agreed that the product allows to do less frictions on the skin during the cleansing.
The studied product was very well dermatological and ophthalmological tolerated by the subjects under retinoids treatment. Moreover, while treatment was being efficient on acne lesions, this cleansing product was able to counteract treatment side effects by restoring the skin hydration level and preserving the cutaneous lipid rate. These results show that its moisturizing and nourishing effectiveness may therefore contribute to a better compliance to ultra-drying acne treatments
Helena Polena1, Michèle Sayag1 and Christelle Graizeau1,2
1NAOS Group, Research and Development Department, Aix-en-Provence, France
2NAOS Institute of Life Science, Aix-en-Provence, France
Create easily your professional account
I create my accountGet access to exclusive dermatological services to increase your professionnal knowledge: +500 pathology visuals, clinical cases, expert videos
Benefit from valuable features: audio listening, materials to be shared with your patients
Stay informed about the upcoming events and webinars, latest scientific publications and product innovations